Published in Appl Microbiol on January 01, 1969
Pyrimidine metabolism in microorganisms. Bacteriol Rev (1970) 7.44
Enzymatic synthesis of pyrimidine nucleotides; orotidine-5'-phosphate and uridine-5'-phosphate. J Biol Chem (1955) 2.64
Inhibition of orotidylic acid decarboxylase, a primary site of carcinostasis by 6-azauracil. Biochim Biophys Acta (1958) 1.70
The uricosuria and orotic aciduria induced by 6-azauridine. J Clin Invest (1961) 1.19
A quantitative evaluation of the mutagenic effect of ethylmethanesulfonate in Brevibacterium ammoniagenes and qualitative character of the mutants obtained. Folia Microbiol (Praha) (1968) 0.92
Smoking during pregnancy and the perinatal cadmium burden. J Perinat Med (1988) 0.95
Azapyrimidine nucleosides: metabolism and inhibitory mechanisms. Adv Enzyme Regul (1985) 0.93
A quantitative evaluation of the mutagenic effect of ethylmethanesulfonate in Brevibacterium ammoniagenes and qualitative character of the mutants obtained. Folia Microbiol (Praha) (1968) 0.92
Detection of cancer stem cell markers in sarcomas. Klin Onkol (2012) 0.80
Loss of coding properties of the trinucleotide guanylyl-uridylyl-uridine on replacement of uridylic by dihydrouridylic acid. Biochim Biophys Acta (1966) 0.80
Mechanism of inhibitory effects of 2,3-dihydro-1,3-6h-oxazine-2,6-dione (3-oxauracil). Biosynthesis of 3-oxauridine phosphates in intact cells and cell-free extracts of Escherichia coli. Biochem Pharmacol (1979) 0.76
Effect of "3-oxauracil" (2,3-dihydro-1,3-6H-oxazine-dione) in L1210 leukemia. Neoplasma (1977) 0.75
Spores of microorganisms. XXII. Inhibition of the postgerminative development of spores of Bacillus cereus by 6-azauracil. Folia Microbiol (Praha) (1967) 0.75
2H-1,3-oxazine-2,6(3H)-dione, a new pyrimidine antimetabolite. Biochem Biophys Res Commun (1973) 0.75
Some cytostatic and pharmacological properties of 2,3-dihydro-1,3-6H-oxazine-2,6-dione ("3-oxauracil"). Neoplasma (1978) 0.75
Inhibitory effect of 5-bromo-6-azauracil on growth and cell division of Saccharomyces cerevisiae. Experientia (1981) 0.75
Cellulolytic activity of bacterial symbionts of wood-destroying insects. Folia Microbiol (Praha) (1977) 0.75
[Functional assays for detection of cancer stem cells]. Klin Onkol (2014) 0.75
Reversed-phase high-performance liquid chromatography of ionogenic compounds: comparison of retention models. J Chromatogr A (1999) 0.75
Resistance of uridine 5'-fluorophosphate to alkaline phosphatase and its sensitivity to 5'-nucleotidase. Biochim Biophys Acta (1971) 0.75
[Injuries to the deciduous teeth and their significance for the permanent dentition]. Zahn Mund Kieferheilkd Zentralbl (1976) 0.75
[Pyrimidine- and purine-type antimetabolites]. Cas Lek Cesk (1972) 0.75
An all-metal block for replica plating of microbial colonies. Folia Microbiol (Praha) (1978) 0.75
The capacity of orotic acid production in pyrimidine-deficient mutants of Brevibacterium ammoniagenes. Folia Microbiol (Praha) (1969) 0.75
[Recirculation at the level of cardiopulmonary circulation. A model depicted on a computer]. Cas Lek Cesk (1983) 0.75
Formation of a dead code triplet through replacement of the terminal ribonucleoside in guanylyl-uridylyl-uridine and guanylyl-uridylyl-cytidine by 6-azacytidine. Mol Pharmacol (1966) 0.75
[Indirect effect of azathymine on the ultraviolet radioresistance of Escherichia coli]. Biologia (Bratisl) (1967) 0.75
Urinary excretion of pseudouridine in the course of x-ray therapy. Neoplasma (1965) 0.75
Dihydro-5-azaorotic acid, the first specific inhibitor of dihydro-orotate dehydrogenase. Biochim Biophys Acta (1968) 0.75
Beta-pyrrolo-L-alanine, a new antimetabolite of phenylalanine and tyrosine in Escherichia coli. Experientia (1966) 0.75